University of Cambridge > > Sensors CDT seminars > Building Biosensors for COVID-19 and Omicron – an industry perspective

Building Biosensors for COVID-19 and Omicron – an industry perspective

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact admin.

Register on Eventbrite:


Zimmer and Peacock has quickly become the UK’s and one of the World’s biggest ISO13485 contract developer and manufacturer of electrochemical biosensors and in-vitro diagnostics, including immunosensors for pathogens.

In this talk we will discuss modern industrial electrochemical biosensors, including COVID -19, but from a commercialisation and manufacturing perspective.


Dr Martin Peacock is an industrial bioelectrochemist with over twenty years of biosensor experience, having had industrial roles from Abbott Diabetes to GSK , and solving technical challenges from continuous glucose monitoring to RNA analysis. In recent years Martin has set-up biosensor focused companies across the globe from Silicon Valley California to Oslo Norway.

At Zimmer and Peacock, we are now distilling our experience into providing a turnkey solution to accelerate our collaborators from their research in the lab to products shipping from the loading bay at the factory. Zimmer and Peacock achieves this acceleration by providing a range of products and services including: sensors, electronics, apps, laboratory testing, Cloud databases, IP generation and turnkey manufacturing.

Zimmer and Peacock works with clients from academia and industry, with the focus always set on getting to market.

Register on Eventbrite:

This talk is part of the Sensors CDT seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity